<script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app22.us.archive.org';v.server_ms=1325;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include --><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<script type="text/javascript" src="/static/js/timestamp.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/graph-calc.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/auto-complete.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/toolbar.js?v=1531166943.0" charset="utf-8"></script>

<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
.wb-autocomplete-suggestions {
    text-align: left; cursor: default; border: 1px solid #ccc; border-top: 0; background: #fff; box-shadow: -1px 1px 3px rgba(0,0,0,.1);
    position: absolute; display: none; z-index: 2147483647; max-height: 254px; overflow: hidden; overflow-y: auto; box-sizing: border-box;
}
.wb-autocomplete-suggestion { position: relative; padding: 0 .6em; line-height: 23px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; font-size: 1.02em; color: #333; }
.wb-autocomplete-suggestion b { font-weight: bold; }
.wb-autocomplete-suggestion.selected { background: #f0f0f0; }
</style>
<div id="wm-ipp" lang="en" style="display:none;direction:ltr;">
<div style="position:fixed;left:0;top:0;right:0;">
<div id="wm-ipp-inside">
  <div style="position:relative;">
    <div id="wm-logo" style="float:left;width:130px;padding-top:10px;">
      <a href="/web/" title="Wayback Machine home page"><img src="/static/images/toolbar/wayback-toolbar-logo.png" alt="Wayback Machine" width="110" height="39" border="0" /></a>
    </div>
    <div class="r" style="float:right;">
      <div id="wm-btns" style="text-align:right;height:25px;">
                  <div id="wm-save-snapshot-success">success</div>
          <div id="wm-save-snapshot-fail">fail</div>
          <a href="#"
             onclick="__wm.saveSnapshot('https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml', '20180610073804')"
             title="Share via My Web Archive"
             id="wm-save-snapshot-open"
          >
            <span class="iconochive-web"></span>
          </a>
          <a href="https://archive.org/account/login.php"
             title="Sign In"
             id="wm-sign-in"
          >
            <span class="iconochive-person"></span>
          </a>
          <span id="wm-save-snapshot-in-progress" class="iconochive-web"></span>
        	<a href="http://faq.web.archive.org/" title="Get some help using the Wayback Machine" style="top:-6px;"><span class="iconochive-question" style="color:rgb(87,186,244);font-size:160%;"></span></a>
	<a id="wm-tb-close" href="#close" onclick="__wm.h(event);return false;" style="top:-2px;" title="Close the toolbar"><span class="iconochive-remove-circle" style="color:#888888;font-size:240%;"></span></a>
      </div>
      <div id="wm-share" style="text-align:right;">
	<a href="#" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=https://web.archive.org/web/20180610073804/https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml', '', 'height=400,width=600'); return false;" title="Share on Facebook" style="margin-right:5px;" target="_blank"><span class="iconochive-facebook" style="color:#3b5998;font-size:160%;"></span></a>
	<a href="#" onclick="window.open('https://twitter.com/intent/tweet?text=https://web.archive.org/web/20180610073804/https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml&amp;via=internetarchive', '', 'height=400,width=600'); return false;" title="Share on Twitter" style="margin-right:5px;" target="_blank"><span class="iconochive-twitter" style="color:#1dcaff;font-size:160%;"></span></a>
      </div>
    </div>
    <table class="c" style="">
      <tbody>
	<tr>
	  <td class="u" colspan="2">
	    <form target="_top" method="get" action="/web/submit" name="wmtb" id="wmtb"><input type="text" name="url" id="wmtbURL" value="https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml" onfocus="this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20180610073804" /><input type="submit" value="Go" /></form>
	  </td>
	  <td class="n" rowspan="2" style="width:110px;">
	    <table>
	      <tbody>
		<!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
		<tr class="m">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180413235800/https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml" title="13 Apr 2018"><strong>Apr</strong></a></td>
		  <td class="c" id="displayMonthEl" title="You are here: 07:38:04 Jun 10, 2018">JUN</td>
		  <td class="f" nowrap="nowrap">Jul</td>
		</tr>
		<!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
		<tr class="d">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180519062140/https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml" title="06:21:40 May 19, 2018"><img src="/static/images/toolbar/wm_tb_prv_on.png" alt="Previous capture" width="14" height="16" border="0" /></a></td>
		  <td class="c" id="displayDayEl" style="width:34px;font-size:24px;white-space:nowrap;" title="You are here: 07:38:04 Jun 10, 2018">10</td>
		  <td class="f" nowrap="nowrap"><img src="/static/images/toolbar/wm_tb_nxt_off.png" alt="Next capture" width="14" height="16" border="0" /></td>
		</tr>
		<!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
		<tr class="y">
		  <td class="b" nowrap="nowrap">2017</td>
		  <td class="c" id="displayYearEl" title="You are here: 07:38:04 Jun 10, 2018">2018</td>
		  <td class="f" nowrap="nowrap">2019</td>
		</tr>
	      </tbody>
	    </table>
	  </td>
	</tr>
	<tr>
	  <td class="s">
	    	    <div id="wm-nav-captures">
	      	      <a class="t" href="/web/20180610073804*/https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml" title="See a list of every capture for this URL">3 captures</a>
	      <div class="r" title="Timespan for captures of this URL">13 Apr 2018 - 10 Jun 2018</div>
	      </div>
	  </td>
	  <td class="k">
	    <a href="" id="wm-graph-anchor">
	      <div id="wm-ipp-sparkline" title="Explore captures for this URL" style="position: relative">
		<canvas id="wm-sparkline-canvas" width="575" height="27" border="0"></canvas>
	      </div>
	    </a>
	  </td>
	</tr>
      </tbody>
    </table>
    <div style="position:absolute;bottom:0;right:2px;text-align:right;">
      <a id="wm-expand" class="wm-btn wm-closed" href="#expand" onclick="__wm.ex(event);return false;"><span id="wm-expand-icon" class="iconochive-down-solid"></span> <span style="font-size:80%">About this capture</span></a>
    </div>
  </div>
    <div id="wm-capinfo" style="border-top:1px solid #777;display:none; overflow: hidden">
            <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center">COLLECTED BY</div>
    <div style="padding:3px;position:relative" id="wm-collected-by-content">
            <div style="display:inline-block;vertical-align:top;width:50%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archiveteam);"></span>
		Organization: <a style="color:#33f;" href="https://archive.org/details/archiveteam" target="_new"><span class="wm-title">Archive Team</span></a>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  <img align=right src="http://archiveteam.org/images/e/e6/Archiveteam.jpg" width=200> Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers and interested parties, and has expanded into a large amount of related projects for saving online and digital history.
<p>
History is littered with hundreds of conflicts over the future of a community, group, location or business that were "resolved" when one of the parties stepped ahead and destroyed what was there. With the original point of contention destroyed, the debates would fall to the wayside. Archive Team believes that by duplicated condemned data, the conversation and debate can continue, as well as the richness and insight gained by keeping the materials. Our projects have ranged in size from a single volunteer downloading the data to a small-but-critical site, to over 100 volunteers stepping forward to acquire terabytes of user-created data to save for future generations.
<p>
The main site for Archive Team is at <a href="http://www.archiveteam.org">archiveteam.org</a> and contains up to the date information on various projects, manifestos, plans and walkthroughs.
<p>
This collection contains the output of many Archive Team projects, both ongoing and completed. Thanks to the generous providing of disk space by the Internet Archive, multi-terabyte datasets can be made available, as well as in use by the <a href="http://archive.org/web/web.php">Wayback Machine</a>, providing a path back to lost websites and work. 
<p>
Our collection has grown to the point of having sub-collections for the type of data we acquire. If you are seeking to browse the contents of these collections, the Wayback Machine is the best first stop. Otherwise, you are free to dig into the stacks to see what you may find.
<p>
<b>The Archive Team Panic Downloads</b> are full pulldowns of currently extant websites, meant to serve as emergency backups for needed sites that are in danger of closing, or which will be missed dearly if suddenly lost due to hard drive crashes or server failures. 
<p>
	</div>
	      </div>
      <div style="display:inline-block;vertical-align:top;width:49%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/archivebot)"></span>
		<div>Collection: <a style="color:#33f;" href="https://archive.org/details/archivebot" target="_new"><span class="wm-title">ArchiveBot: The Archive Team Crowdsourced Crawler</span></a></div>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  ArchiveBot is an IRC bot designed to automate the archival of smaller websites (e.g. up to a few hundred thousand URLs). You give it a URL to start at, and it grabs all content under that URL, records it in a WARC, and then uploads that WARC to ArchiveTeam servers for eventual injection into the Internet Archive (or other archive sites).
<p>
To use ArchiveBot, drop by #archivebot on EFNet. To interact with ArchiveBot, you issue commands by typing it into the channel. Note you will need channel operator permissions in order to issue archiving jobs. The dashboard shows the sites being downloaded currently.
<p>
There is a dashboard running for the archivebot process at <a href="http://www.archivebot.com">http://www.archivebot.com</a>.
<p>
ArchiveBot's source code can be found at <a href="https://github.com/ArchiveTeam/ArchiveBot">https://github.com/ArchiveTeam/ArchiveBot</a>.
	</div>
	      </div>
    </div>
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center" title="Timestamps for the elements of this page">TIMESTAMPS</div>
    <div>
      <div id="wm-capresources" style="margin:0 5px 5px 5px;max-height:250px;overflow-y:scroll !important"></div>
      <div id="wm-capresources-loading" style="text-align:left;margin:0 20px 5px 5px;display:none"><img src="/static/images/loading.gif" alt="loading" /></div>
    </div>
  </div></div></div></div><script type="text/javascript">
__wm.bt(575,27,25,2,"web","https://www.guideline.gov/summaries/downloadcontent/ngc-11280?contentType=xml","2018-06-10",1996);
</script>
<!-- END WAYBACK TOOLBAR INSERT --><version>
  <xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource>
  <section secid="390" ordby="100" name="General">
    <field fieldid="161" ordby="105" id="391" name="Guideline Title" type="text">
      <fieldvalue value="<div class=&quot;content_title&quot;>Breakthrough cancer pain: a systematic review of pharmacologic management.</div>"/>
    </field>
    <field fieldid="97" ordby="110" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Brant JM, Rodgers BB, Gallagher E, Sundaramurthi T. Breakthrough cancer pain: a systematic review of pharmacologic management. Clin J Oncol Nurs. 2017 Jun 1;21(3):71-80. <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=28524907 &quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="120" ordby="115" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Aiello-Laws L, Reynolds J, Deizer N, Peterson M, Ameringer S, Bakitas M. Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults. Clin J Oncol Nurs. 2009 Dec;13(6):649-55. [55 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
  </section>
  <section secid="705" ordby="150" name="NEATS Assessment">
    <field fieldid="183" ordby="10" id="706" name="Disclosure of Guideline Funding Source" type="picklist-one">
      <fieldvalue value="No"/>
    </field>
    <field fieldid="184" ordby="20" id="707" name="Disclosure and Management of Financial Conflict of Interests" type="picklist-one">
      <fieldvalue value="3"/>
    </field>
    <field fieldid="185" ordby="30" id="708" name="Guideline Development Group Composition: Multidisciplinary Group" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="186" ordby="40" id="709" name="Guideline Development Group Composition: Methodologist Involvement" type="picklist-one">
      <fieldvalue value="Yes"/>
    </field>
    <field fieldid="187" ordby="50" id="710" name="Guideline Development Group Composition: Patient and Public Perspectives" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
    <field fieldid="188" ordby="60" id="711" name="Use of a Systematic Review of Evidence: Search Strategy" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="189" ordby="70" id="712" name="Use of a Systematic Review of Evidence: Study Selection" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="190" ordby="80" id="713" name="Use of a Systematic Review of Evidence: Synthesis of Evidence" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="191" ordby="90" id="714" name="Evidence Foundations for and Rating Strength of Recommendations: Grading the Quality or Strength of Evidence" type="picklist-one">
      <fieldvalue value="3"/>
    </field>
    <field fieldid="192" ordby="100" id="715" name="Evidence Foundations for and Rating Strength of Recommendations: Benefits and Harms of Recommendations" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="193" ordby="110" id="716" name="Evidence Foundations for and Rating Strength of Recommendations: Evidence Summary Supporting Recommendations" type="picklist-one">
      <fieldvalue value="5"/>
    </field>
    <field fieldid="194" ordby="120" id="717" name="Evidence Foundations for and Rating Strength of Recommendations: Rating the Strength of Recommendations" type="picklist-one">
      <fieldvalue value="4"/>
    </field>
    <field fieldid="195" ordby="130" id="718" name="Specific and Unambiguous Articulation of Recommendations" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
    <field fieldid="196" ordby="140" id="719" name="External Review" type="picklist-one">
      <fieldvalue value="1"/>
    </field>
    <field fieldid="197" ordby="150" id="720" name="Updating" type="picklist-one">
      <fieldvalue value="2"/>
    </field>
  </section>
  <section secid="420" ordby="300" name="Recommendations">
    <field fieldid="151" ordby="310" id="421" name="Major Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Note from the National Guideline Clearinghouse (NGC)</strong>: Refer to the original guideline document for full dosages, references, and other essential information about the evidence. The recommendation ratings (<strong>Recommended for Practice, Likely To Be Effective, Effectiveness Not Established, Effectiveness Unlikely, Not Recommended for Practice, Expert Opinion</strong>) are defined at the end of the &quot;Major Recommendations&quot; field.</p>
<p>See also the NGC summaries of the related Oncology Nursing Society (ONS) guidelines on cancer-related pain:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li><a href=&quot;/summaries/summary/51124&quot; title=&quot;Guideline #11278&quot; target=&quot;_blank&quot;>Cancer-related acute pain: a systematic review of evidence-based interventions for Putting Evidence Into Practice</a>. </li>
    <li><a href=&quot;/summaries/summary/51125&quot; title=&quot;Guideline #11279&quot; target=&quot;_blank&quot;>Chronic and refractory pain: a systematic review of pharmacologic management in oncology</a>. </li>
    <li><a href=&quot;/summaries/summary/51127&quot; title=&quot;Guideline #11281&quot; target=&quot;_blank&quot;>Nonpharmacologic pain interventions: a review of evidence-based practices for reducing chronic cancer pain</a>. </li>
</ul>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Recommended for Practice</span></strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Oral opioids </li>
    <li>Transmucosal immediate-release fentanyl </li>
    <li>Opioids at proportional dose to basal dose </li>
</ul>
<p><strong>Effectiveness Not Established</strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Intravenous (IV) flurbiprofen </li>
    <li>Intranasal sufentanil </li>
</ul>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Definitions</span></strong></p>
<p><strong>Recommended for Practice</strong></p>
<p>Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analysis, or systematic reviews, and for which expectation of harms is small compared to the benefits</p>
<p><strong>Likely To Be Effective</strong></p>
<p>Interventions for which effectiveness has been demonstrated from a single rigorously designed conducted controlled trial, consistent supportive evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion </p>
<p><strong>Benefits Balanced With Harm</strong></p>
<p>Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities</p>
<p><strong>Effectiveness Not Established</strong></p>
<p>Interventions for insufficient or conflicting data or data of inadequate quality currently exist, with no clear indication of harm</p>
<p><strong>Effectiveness Unlikely</strong></p>
<p>Interventions for which lack of effectiveness has been demonstrated by negative evidence from a single rigorously conducted controlled trial, consistent negative evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion</p>
<p><strong>Not Recommended for Practice</strong></p>
<p>Interventions for which lack of effectiveness or harmfulness has been demonstrated by strong evidence from rigorously conducted studies, meta-analyses, or systematic reviews, or interventions where the costs, burden, or harm associated with the intervention exceed anticipated benefit</p>
<p><strong>Expert Opinion</strong></p>
<p>Low-risk interventions that are consistent with sound clinical practice, suggested by an expert in a peer reviewed publication, and for which limited evidence exists (an expert is an individual who has published peer reviewed material in the domain of interest.)</p>
<p>For further information, see the &quot;Decision rules for summative evaluation of a body of evidence&quot; document (see the &quot;Availability of Companion Documents&quot; field). </p></div>"/>
    </field>
    <field fieldid="138" ordby="330" id="423" name="Clinical Algorithm(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None provided</p></div>"/>
    </field>
  </section>
  <section secid="396" ordby="400" name="Scope">
    <field fieldid="140" ordby="405" id="397" name="Disease/Condition(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Breakthrough cancer pain</p></div>"/>
    </field>
    <field fieldid="103" ordby="410" id="398" name="Guideline Category" type="picklist-many">
      <fieldvalue value="Management"/>
      <fieldvalue value="Treatment"/>
    </field>
    <field fieldid="113" ordby="415" id="399" name="Clinical Specialty" type="picklist-many">
      <fieldvalue value="Nursing"/>
      <fieldvalue value="Oncology"/>
    </field>
    <field fieldid="114" ordby="420" id="400" name="Intended Users" type="picklist-many">
      <fieldvalue value="Advanced Practice Nurses"/>
      <fieldvalue value="Health Care Providers"/>
      <fieldvalue value="Nurses"/>
    </field>
    <field fieldid="129" ordby="425" id="401" name="Guideline Objective(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>To identify evidence-based pharmacologic modalities to adequately manage breakthrough cancer pain (BtCP)</p></div>"/>
    </field>
    <field fieldid="132" ordby="430" id="402" name="Target Population" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Patients with breakthrough cancer pain</p></div>"/>
    </field>
    <field fieldid="133" ordby="435" id="403" name="Interventions and Practices Considered" type="text">
      <fieldvalue value="<ol style=&quot;list-style-type: decimal;&quot;>
    <li>Oral opioids</li>
    <li>Transmucosal immediate-release fentanyl</li>
    <li>Dosing of opioids at a proportional dose to basal dose </li>
</ol>
<p class=&quot;Note&quot;><strong>Note</strong>: The following were considered, but their effectiveness is not established: intravenous (IV) flurbiprofen, intranasal sufentanil.</p>"/>
    </field>
    <field fieldid="134" ordby="440" id="404" name="Major Outcomes Considered" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Pain intensity/relief </li>
    <li>Quality of life </li>
    <li>Side effects of opioids</li>
</ul>"/>
    </field>
  </section>
  <section secid="405" ordby="500" name="Methodology">
    <field fieldid="109" ordby="505" id="406" name="Methods Used to Collect/Select the Evidence" type="picklist-many">
      <fieldvalue value="Searches of Electronic Databases"/>
    </field>
    <field fieldid="135" ordby="510" id="407" name="Description of Methods Used to Collect/Select the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>A thorough search of PubMed and CINAHL&amp;reg; from January 1, 2009 to July 31, 2016 was conducted.</p>
<p>The Oncology Nursing Society (ONS) Putting Evidence Into Practice (PEP) program conducted a literature search for pain prior to 2009. Thirty-four articles from the previous search were included in the cancer-related pain guidelines. These articles were subject to the same inclusion and exclusion criteria as the articles for the new search. </p>
<p>Studies published from January 2006 to June 2016 are included in the review.</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Pain Topic Search Strategy</span></strong></p>
<p>The following strategy was used across all four pain guidelines (see the &quot;Major Recommendations&quot; field).</p>
<p><strong>Databases Used</strong></p>
<p><em>PubMed</em> </p>
<p>(pain[ti] AND cancer[ti]) OR ((pain[ti] OR pain[majr]) AND neoplasms[majr]) AND ((&quot;2009/01/01&quot;[PDAT] : &quot;2016/07/31&quot;[PDAT]) AND &quot;humans&quot;[MeSH Terms] AND English[lang] AND cancer[sb]) </p>
<p><em>CINAHL&amp;reg;</em> </p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>(MH &quot;Cancer Pain&quot; OR (TI cancer AND TI pain)) OR ( MM pain AND (cancer OR neoplasms OR oncolog*)) </li>
    <li>Limiters: English language; clinical queries: therapy&amp;ndash;high sensitivity, therapy&amp;ndash;high specificity, therapy&amp;ndash;best balance </li>
</ul>
<p><strong>Inclusion Criteria</strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Full research report, systematic review, guideline, or meta-analysis </li>
    <li>Study must report results of measurement of pain, including acute, chronic, breakthrough, or refractory pain. </li>
    <li>The study examines a pharmacologic or nonpharmacologic intervention aimed at affecting pain. </li>
    <li>Sample must include patients with cancer. </li>
    <li>Include pediatric and/or adult studies </li>
    <li>Studies aimed at treatment of pain (may include other symptoms) rather than treatment of the cancer </li>
    <li>Sample size of at least 40, or 20 per study group </li>
    <li>For complex interventions, the description of the intervention must be sufficient to identify the components of that intervention. </li>
</ul>
<p><strong>Exclusion Criteria</strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Gray literature </li>
    <li>Descriptive study </li>
    <li>Studies involving the use of standard short-acting or sustained or extended-release opioids (Only studies involving new formulations or unusual use of these medications will be included.) </li>
    <li>Studies involving examination of effects of different types of surgical anesthesia </li>
    <li>Studies involving surgical procedures as the primary intervention </li>
</ul></div>"/>
    </field>
    <field fieldid="136" ordby="515" id="408" name="Number of Source Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Forty-four citations are included in the review for breakthrough cancer pain.</p></div>"/>
    </field>
    <field fieldid="115" ordby="520" id="409" name="Methods Used to Assess the Quality and Strength of the Evidence" type="picklist-choice">
      <fieldvalue value="Expert Consensus (Committee)"/>
      <fieldvalue value="Weighting According to a Rating Scheme (Scheme Given)"/>
    </field>
    <field fieldid="149" ordby="525" id="410" name="Rating Scheme for the Strength of the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Panels of advanced practice nurses, staff nurses, and doctorally-prepared nurse researchers reviewed the literature base in the identified outcome areas. Professional health services librarians assisted in the conduct of the literature searches. Based on their analysis, the panels then formulated a judgment about the body of evidence related to the intervention under consideration. Three major components were considered by the panels in classifying the collective evidence into one of six Weight of Evidence categories (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field): </p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Quality of the data, with more weight assigned to levels of evidence higher in the PRISM categorization (such as randomized trials and meta-analyses) </li>
    <li>Magnitude of the outcome (e.g., effect size or minimal clinically important difference) </li>
    <li>Concurrence among the evidence (based on the premise that an investigator has less confidence in findings in which the lines of evidence contradict one another) </li>
</ul></div>"/>
    </field>
    <field fieldid="116" ordby="530" id="411" name="Methods Used to Analyze the Evidence" type="picklist-many">
      <fieldvalue value="Review of Published Meta-Analyses"/>
      <fieldvalue value="Systematic Review with Evidence Tables"/>
    </field>
    <field fieldid="150" ordby="535" id="412" name="Description of the Methods Used to Analyze the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The Oncology Nursing Society (ONS) information resources supervisor thoroughly searched the literature according to the strategy and search terms shown the &quot;Description of Methods Used to Collect/Select the Evidence&quot; field. Studies that met inclusion criteria were assigned to pairs of pain Putting Evidence Into Practice (PEP) team members, who reviewed and summarized included articles using a standard form. Each article was reviewed by one pain PEP team member and then peer-reviewed by the second pain PEP team member. The form included information about the purpose of the study and a brief description of the intervention, sample size and characteristics, study design, measurement instruments, conclusions, limitations that show risk of bias and threats to validity in design, and implications for nursing practice. Finally, PEP team members applied the ONS PEP classification scheme to individual interventions via Web-based meetings occurring about every six months. PEP team members included nurse scientists, advanced practice nurses, and staff nurses. Classification considers all previous as well as new evidence for each intervention. Conferences are facilitated by ONS research staff and classification of individual interventions is determined by team consensus.</p></div>"/>
    </field>
    <field fieldid="112" ordby="540" id="413" name="Methods Used to Formulate the Recommendations" type="picklist-choice">
      <fieldvalue value="Expert Consensus"/>
    </field>
    <field fieldid="145" ordby="545" id="414" name="Description of Methods Used to Formulate the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The Putting Evidence Into Practice (PEP) program is a multifaceted project that involves the coordination of Oncology Nursing Society (ONS) staff as well as volunteer team contributors. PEP topic teams are comprised of volunteer nurse researchers, advanced practice nurses, and staff nurses who have demonstrated experience and interest in a PEP topic. Topic leaders are nurse scientists or advanced practice nurses with demonstrated expertise in the topic through research and/or publications.</p>
<p>PEP team members applied the ONS PEP classification scheme (see the &quot;Rating Scheme for the Recommendations&quot; field) to individual interventions via Web-based meetings occurring about every six months. PEP team members included nurse scientists, advanced practice nurses, and staff nurses. Classification considers all previous as well as new evidence for each intervention. Conferences are facilitated by ONS research staff and classification of individual interventions is determined by team consensus.</p>
<p>Teams categorize interventions based on the ONS PEP weight-of-evidence classification schema. The schema is intended to be used with existing research-based knowledge on health interventions and is based on previous research. PEP teams consider the entire body of evidence rather than a single study for classification, and more weight is given to studies that rank higher in ONS's priority symptom management project categorization. Team members also consider the magnitude of the outcome and the concurrence of the evidence for an intervention prior to assigning a classification. Interventions are classified by team consensus after application of the schema.</p></div>"/>
    </field>
    <field fieldid="146" ordby="550" id="415" name="Rating Scheme for the Strength of the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong><span style=&quot;text-decoration: underline;&quot;>Recommended for Practice</span></strong></p>
<p>Interventions for which effectiveness has been demonstrated by strong evidence from rigorously designed studies, meta-analysis, or systematic reviews, and for which expectation of harms is small compared to the benefits</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Likely To Be Effective</span></strong></p>
<p>Interventions for which effectiveness has been demonstrated from a single rigorously designed conducted controlled trial, consistent supportive evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion </p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Benefits Balanced With Harm</span></strong></p>
<p>Interventions for which clinicians and patients should weigh the beneficial and harmful effects according to individual circumstances and priorities</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Effectiveness Not Established</span></strong></p>
<p>Interventions for insufficient or conflicting data or data of inadequate quality currently exist, with no clear indication of harm</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Effectiveness Unlikely</span></strong></p>
<p>Interventions for which lack of effectiveness has been demonstrated by negative evidence from a single rigorously conducted controlled trial, consistent negative evidence from well-designed controlled trials using small samples, or guidelines developed from evidence and supported by expert opinion</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Not Recommended for Practice</span></strong></p>
<p>Interventions for which lack of effectiveness or harmfulness has been demonstrated by strong evidence from rigorously conducted studies, meta-analyses, or systematic reviews, or interventions where the costs, burden, or harm associated with the intervention exceed anticipated benefit</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Expert Opinion</span></strong></p>
<p>Low-risk interventions that are consistent with sound clinical practice, suggested by an expert in a peer reviewed publication, and for which limited evidence exists (an expert is an individual who has published peer reviewed material in the domain of interest.)</p>
<p>For further information, see the &quot;Decision rules for summative evaluation of a body of evidence&quot; document (see the &quot;Availability of Companion Documents&quot; field). </p></div>"/>
    </field>
    <field fieldid="148" ordby="565" id="417" name="Cost Analysis" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>"/>
    </field>
    <field fieldid="104" ordby="570" id="418" name="Method of Guideline Validation" type="picklist-choice">
      <fieldvalue value="External Peer Review"/>
    </field>
    <field fieldid="130" ordby="575" id="419" name="Description of Method of Guideline Validation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The article has been reviewed by independent peer reviewers to ensure that it is objective and free from bias.</p></div>"/>
    </field>
  </section>
  <section secid="424" ordby="600" name="Evidence Supporting the Recommendations">
    <field fieldid="139" ordby="610" id="426" name="Type of Evidence Supporting the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The type of supporting evidence is identified for each recommendation (see the original guideline document).</p></div>"/>
    </field>
  </section>
  <section secid="427" ordby="700" name="Benefits/Harms of Implementing the Guideline Recommendations">
    <field fieldid="152" ordby="705" id="428" name="Potential Benefits" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Two systematic reviews of almost 6,000 patients concluded that morphine, oxycodone, and hydromorphone (Dilaudid&amp;reg;) are effective in managing cancer pain, which included breakthrough cancer pain (BtCP). </li>
    <li>In 25 individual studies of transmucosal immediate-release fentanyl (TIRF) products, pain was reduced compared to baseline in all trials. TIRF products were well tolerated and were rarely discontinued because of adverse effects. One trial noted a decrease in anxiety and depression along with the reduction in pain. </li>
</ul>"/>
    </field>
    <field fieldid="153" ordby="710" id="429" name="Potential Harms" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>In 25 individual studies, transmucosal immediate-release fentanyl (TIRF) products were well tolerated and were rarely discontinued because of adverse effects, except in one study in which 26% of patients reported adverse effects with intranasal fentanyl spray (INFS). The most common adverse effects were dizziness, vomiting, constipation, and somnolence. </p></div>"/>
    </field>
  </section>
  <section secid="432" ordby="900" name="Qualifying Statements">
    <field fieldid="137" ordby="905" id="433" name="Qualifying Statements" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The authors take full responsibility for the content of the article. The authors did not receive honoraria for this work. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias.</p></div>"/>
    </field>
  </section>
  <section secid="434" ordby="1000" name="Implementation of the Guideline">
    <field fieldid="131" ordby="1010" id="436" name="Description of Implementation Strategy" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>An implementation strategy was not provided.</p></div>"/>
    </field>
    <field fieldid="117" ordby="1015" id="437" name="Implementation Tools" type="picklist-many">
      <fieldvalue value="Resources"/>
      <fieldvalue value="Staff Training/Competency Material"/>
    </field>
  </section>
  <section secid="439" ordby="1100" name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <field fieldid="50" ordby="1105" id="440" name="IOM Care Need" type="picklist-many">
      <fieldvalue value="Getting Better"/>
      <fieldvalue value="Living with Illness"/>
    </field>
    <field fieldid="51" ordby="1110" id="441" name="IOM Domain" type="picklist-many">
      <fieldvalue value="Effectiveness"/>
      <fieldvalue value="Patient-centeredness"/>
    </field>
  </section>
  <section secid="442" ordby="1200" name="Identifying Information and Availability">
    <field fieldid="97" ordby="1201" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Brant JM, Rodgers BB, Gallagher E, Sundaramurthi T. Breakthrough cancer pain: a systematic review of pharmacologic management. Clin J Oncol Nurs. 2017 Jun 1;21(3):71-80. <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=28524907 &quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="124" ordby="1205" id="443" name="Adaptation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable: The guideline was not adapted from another source.</p></div>"/>
    </field>
    <field fieldid="128" ordby="1215" id="445" name="Date Released" type="text">
      <fieldvalue value="2017 Jun 1"/>
    </field>
    <field fieldid="158" ordby="1225" id="447" name="Guideline Developer(s)" type="orglist-p">
      <fieldvalue value="Oncology Nursing Society - Professional Association"/>
    </field>
    <field fieldid="125" ordby="1235" id="449" name="Source(s) of Funding" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Oncology Nursing Society</p></div>"/>
    </field>
    <field fieldid="126" ordby="1240" id="450" name="Guideline Committee" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Oncology Nursing Society Putting Evidence Into Practice&amp;reg; (ONS PEP) Expert Panel</p></div>"/>
    </field>
    <field fieldid="127" ordby="1245" id="451" name="Composition of Group That Authored the Guideline" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><em>Authors</em>: Jeannine M. Brant, PhD, APRN, AOCN<sup>&amp;reg;</sup>, FAAN; Barbara B. Rodgers, CRNP, MN, AOCN<sup>&amp;reg;</sup>, ANP-BC; Eva Gallagher, PhD; Thiruppavai Sundaramurthi, RN, PhD, CCRN, OCN<sup>&amp;reg;</sup></p></div>"/>
    </field>
    <field fieldid="147" ordby="1250" id="452" name="Financial Disclosures/Conflicts of Interest" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>All volunteers complete the standardized Oncology Nursing Society (ONS) conflict of interest and confidentiality forms.</p>
<p>The authors take full responsibility for this content. Brant is a member of the speakers bureau for Subsys.</p></div>"/>
    </field>
    <field fieldid="120" ordby="1256" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Aiello-Laws L, Reynolds J, Deizer N, Peterson M, Ameringer S, Bakitas M. Putting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults. Clin J Oncol Nurs. 2009 Dec;13(6):649-55. [55 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div>"/>
    </field>
    <field fieldid="118" ordby="1260" id="454" name="Guideline Availability" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Available to subscribers from the <a href=&quot;https://cjon.ons.org/cjon/21/3/supplement/breakthrough-cancer-pain-systematic-review-pharmacologic-management&quot; title=&quot;Clinical Journal of Oncology Nursing Web site&quot;>Clinical Journal of Oncology Nursing Web site</a>.</p></div>"/>
    </field>
    <field fieldid="119" ordby="1265" id="455" name="Availability of Companion Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The following are available:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Brant JM, Eaton LH, Irwin MM. Cancer-related pain: assessment and management with Putting Evidence Into Practice interventions. Clin J Oncol Nurs. 2017 Jun 1;21(3):4-7. Available to subscribers from the <a href=&quot;https://cjon.ons.org/cjon/21/3/supplement/cancer-related-pain-assessment-and-management-putting-evidence-practice&quot; title=&quot;Clinical Journal of Oncology Nursing Web site&quot;>Clinical Journal of Oncology Nursing Web site</a>. </li>
    <li>Breakthrough pain. [internet]. Pittsburgh (PA): Oncology Nursing Society. 2017 Mar 30. Available from the <a href=&quot;https://www.ons.org/practice-resources/pep/pain/breakthrough-pain&quot; title=&quot;Oncology Nursing Society (ONS) Web site&quot;>Oncology Nursing Society (ONS) Web site</a>. </li>
    <li>Mitchell SA, Friese CR. Decision rules for summative evaluation of a body of evidence. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href=&quot;https://www.ons.org/practice-resources/pep/evaluation-process&quot; title=&quot;ONS Web site&quot;>ONS Web site</a>. </li>
    <li>Johnson LA. Putting Evidence Into Practice: the process for evidence-based research. Clin J Oncol Nurs. 2014 Dec;18(6 Suppl):2-4. Available from the <a href=&quot;https://cjon.ons.org/cjon/18/6/supplement/putting-evidence-practice-process-evidence-based-research&quot; title=&quot;Clinical Journal of Oncology Nursing Web site&quot;>Clinical Journal of Oncology Nursing Web site</a>. </li>
    <li>Putting Evidence Into Practice (PEP) rating system overview. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href=&quot;https://www.ons.org/practice-resources/pep&quot; title=&quot;ONS Web site&quot;>ONS Web site</a>. </li>
    <li>ONS journal activity 2017: breakthrough cancer pain: a systematic review of pharmacologic management. [internet]. Pittsburgh (PA): Oncology Nursing Society. Available from the <a href=&quot;https://www.ons.org/content/ons-journal-activity-2017-breakthrough-cancer-pain-systematic-review-pharmacologic&quot; title=&quot;ONS Web site&quot;>ONS Web site</a>. </li>
</ul></div>"/>
    </field>
    <field fieldid="143" ordby="1275" id="457" name="Patient Resources" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None available</p></div>"/>
    </field>
    <field fieldid="142" ordby="1280" id="458" name="NGC Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary was completed by ECRI Institute on December 3, 2010. The information was verified by the guideline developer on February 3, 2011. This summary was updated by ECRI Institute on October 28, 2013 following the U.S. Food and Drug Administration advisory on Acetaminophen. The currency of the guideline was reaffirmed by the developer in 2011 and this summary was updated by ECRI Institute on November 8, 2013. This summary was updated by ECRI Institute on September 18, 2015 following the U.S. Food and Drug Administration advisory on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs). This summary was updated by ECRI Institute on February 5, 2018. The updated information was verified by the guideline developer on February 21, 2018.</p>
<p>This NEATS assessment was completed by ECRI Institute on November 16, 2017. The information was verified by the guideline developer on February 21, 2018.</p></div>"/>
    </field>
    <field fieldid="141" ordby="1290" id="460" name="Copyright Statement" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This summary is based on the original guideline, which is copyrighted by the Oncology Nursing Society (ONS).</p></div>"/>
    </field>
  </section>
  <section secid="99999" ordby="99999" name="Disclaimer">
    <field fieldid="99999" ordby="99999" id="99999" name="NGC Disclaimer" type="text">
      <fieldvalue value="<p>The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;>NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>"/>
    </field>
  </section>
</version><!--
     FILE ARCHIVED ON 07:38:04 Jun 10, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:29:06 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 686.512 (3)
  esindex: 0.015
  captures_list: 727.596
  CDXLines.iter: 16.819 (3)
  PetaboxLoader3.datanode: 144.081 (4)
  exclusion.robots: 0.513
  exclusion.robots.policy: 0.488
  RedisCDXSource: 19.492
  PetaboxLoader3.resolve: 107.316
  load_resource: 557.706
-->